SynthBee Appoints Skunk Works Leader John G. Clark as SVP to Accelerate Customer Deployments & Innovation


SynthBee Collaborative Intelligence™ Platform Continues to Evolve as Company & Customer Engagement Grows

FORT LAUDERDALE, Fla., Nov. 20, 2025 /PRNewswire/ — SynthBee, Inc., a stealth tech start-up pioneering its Collaborative Intelligence™ (CI™) platform, announced the appointment of John G. Clark as Senior Vice President of Engineering Systems & Manufacturing Operations. John brings his almost three decades of AI, software systems design, hardware, electronics, advanced manufacturing and product development expertise to help SynthBee’s enterprise business customers across diverse industries.

John was most recently the Senior Vice-President for Technology and Strategic Innovation for Lockheed Martin and previously served as its Vice-President and General Manager of Lockheed’s Skunk Works® where he focused on designing and developing the most advanced aircraft in the Department of Defense (DoD) ecosystem. He brings a proven, collaborative, and specialized innovation with purpose approach to SynthBee’s current and future customers spanning medical technology and healthcare, aerospace and defense, manufacturing, automotive, financial services and other key tech/media industries.

“My passion for rapid innovation to build tomorrow’s products aligns with SynthBee and its proprietary CI™ platform,” said John Clark, SVP, Engineering Systems and Manufacturing Operations at SynthBee. “The Skunk Works® model – ‘be quick, be quiet, be on time,’ as its founder Kelly Johnson put it – translates perfectly to the fast-paced challenges facing every industry today. I’m excited to help SynthBee, and its customers accelerate meaningful advances in human-computing collaboration.”

Many large-scale, opaque and often hallucinating systems chasing Artificial General Intelligence (AGI) contend with major accuracy, security, trust, governance, and ethical hurdles. SynthBee’s CI™ platform prioritizes human-centered design, trust, privacy, and transparent, accurate outcomes. This approach empowers businesses to solve complex scientific, engineering, design, and creative challenges more safely and effectively.

SynthBee was founded by Rony Abovitz, whose previous ventures – MAKO Surgical, acquired by Stryker for $1.65B, and Magic Leap – set new standards in surgical robotics and spatial computing/XR. MAKO’s success showed how collaborative robotics can positively transform clinical outcomes by blending the best of people with human-friendly machines (inspired by R2D2).

The MAKO RIO robot became part of the surgical team, generating significant and proven clinical, operational, and financial value for hospitals. SynthBee’s CI™ platform aims to replicate this impact for a wide array of businesses, across many industries in the United States and around the free world.

“John brings a hands-on, fast, agile, and brilliant Skunk Works® innovation ethos and rapid product development leadership and world-class excellence to our team,” said Rony Abovitz, president & CEO at SynthBee. “Since last year’s seed funding announcement, we’ve grown our team, customer engagements and advanced our unique CI™ platform. We are focused on constantly improving our capabilities to help customers innovate faster and outpace the competition in non-linear ways.”

Interested in joining our mission? Explore job opportunities here.


About SynthBee, Inc.

SynthBee, Inc. is building safe, scalable, and reliable computing intelligence to amplify and accelerate human innovation. www.synthbee.com


Contact




media@synthbee.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/synthbee-appoints-skunk-works-leader-john-g-clark-as-svp-to-accelerate-customer-deployments–innovation-302621310.html

SOURCE SynthBee, Inc.

Staff

Recent Posts

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

14 minutes ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…

14 minutes ago

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…

14 minutes ago

A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal

This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally…

3 hours ago

Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure

KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…

9 hours ago

Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026

LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…

15 hours ago